Study Effect of Baicalein Encapsulated/loaded Chitosan-nanoparticle on Allergic Asthma Pathology in Mouse Model

Overview

Journal Saudi J Biol Sci

Specialty Biology

Date 2021 Aug 6

PMID 34354413

Citations 14

Authors

Dong Wang

Entezar Mehrabi Nasab

Seyyed Shamsadin Athari

Affiliations

Soon will be listed here.

Abstract

Asthma as chronic airway disease has high prevalence in children and imbalance of Th1/Th2 is a critical mechanism in pathogenesis of the asthma. Baicalein as a cell protective and anti-inflammatory flavonoid may have anti-asthma effect. Therefore, for better using lung, baicalein was used in chitosan-nanoparticle as anti-asthma treatment. Baicalein was loaded and encapsulated in chitosan nanoparticle. The morphology, physical characters (particle size, zeta potential and FT-IR) were analyzed. Drug encapsulation and loading capacity, accumulative release-time were studied. After asthma model producing, the mice were treated with L-B-NP and E-B-NP. At least, MCh challenge test, Cytokines measurement and Lung Histopathology were done. Nanoparticles had average size 285 ± 25 nm with negative charge -2.5 mV. The L-B-NP decreased penh value and E-B-NP decreased inflammation. Both nanoparticles increased IL-12 and decreased IL-5. Also, L-B-NP decreased mucus secretion in bronchi. L-B-NP and E-B-NP control immune-allergo-inflammatory response of asthma. L-B-NP controlled AHR and E-B-NP controlled inflammation that can be used as controlling anti-asthma drug.

Citing Articles

Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases.

Cui L, Yang Y, Hao Y, Zhao H, Zhang Y, Wu T Clin Rev Allergy Immunol. 2025; 68(1):12.

PMID: 39928241 PMC: 11811441. DOI: 10.1007/s12016-024-09019-w.

Recent advances in self-targeting natural product-based nanomedicines.

Liu H, Jin X, Liu S, Liu X, Pei X, Sun K J Nanobiotechnology. 2025; 23(1):31.

PMID: 39833846 PMC: 11749302. DOI: 10.1186/s12951-025-03092-9.

Baicalein attenuates ovalbumin-induced allergic rhinitis through the activation of nuclear receptor subfamily 4 group a member 1.

Xu Y, Xu L, Jian X, Wang Q, Li Z, Ge H Immunol Res. 2025; 73(1):32.

PMID: 39808359 DOI: 10.1007/s12026-024-09590-6.

Nanoparticles to target asthma.

Hamrick S, Thompson M, Rotello V, Prakash Y, Pabelick C Am J Physiol Lung Cell Mol Physiol. 2024; 327(6):L964-L971.

PMID: 39470612 PMC: 11684954. DOI: 10.1152/ajplung.00248.2024.

Studying of anti-inflammatory and antioxidant effects of tectorigenin in ovalbumin-induced asthma mice models.

Guo J, Shi Y, Wang Y, Athari S, Chen T Clin Respir J. 2024; 18(4):e13742.

PMID: 38664220 PMC: 11045443. DOI: 10.1111/crj.13742.

References

Babu V, Kannan S . Enhanced delivery of baicalein using cinnamaldehyde cross-linked chitosan nanoparticle inducing apoptosis. Int J Biol Macromol. 2012; 51(5):1103-8. DOI: 10.1016/j.ijbiomac.2012.08.038. View

Huang S, Lee Y, Gullen E, Cheng Y . Impacts of baicalein analogs with modification of the 6th position of A ring on the activity toward NF-kappaB-, AP-1-, or CREB-mediated transcription. Bioorg Med Chem Lett. 2008; 18(18):5046-9. PMC: 2645231. DOI: 10.1016/j.bmcl.2008.08.001. View

Athari S, Athari S, Beyzay F, Movassaghi M, Mortaz E, Taghavi M . Critical role of Toll-like receptors in pathophysiology of allergic asthma. Eur J Pharmacol. 2016; 808:21-27. DOI: 10.1016/j.ejphar.2016.11.047. View

Shin H, Bae M, Jung S, Shon D . Inhibitory effect of skullcap (Scutellaria baicalensis) extract on ovalbumin permeation in vitro and in vivo. Food Chem. 2013; 140(1-2):22-30. DOI: 10.1016/j.foodchem.2013.01.042. View

. How Do You Treat in Your Practice?. Med Acupunct. 2018; 30(2):100-112. PMC: 6011376. DOI: 10.1089/acu.2018.29078.cpl. View

Li J, Jin X, Yang Y, Zhang L, Liu R, Li Z . Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation. Int J Biol Macromol. 2020; 156:749-761. DOI: 10.1016/j.ijbiomac.2020.04.115. View

Yin H, Huang L, Ouyang T, Chen L . Baicalein improves liver inflammation in diabetic db/db mice by regulating HMGB1/TLR4/NF-κB signaling pathway. Int Immunopharmacol. 2017; 55:55-62. DOI: 10.1016/j.intimp.2017.12.002. View

de Oliveira M, Nabavi S, Habtemariam S, Orhan I, Daglia M, Nabavi S . The effects of baicalein and baicalin on mitochondrial function and dynamics: A review. Pharmacol Res. 2015; 100:296-308. DOI: 10.1016/j.phrs.2015.08.021. View

Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M . Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017; 131:68-80. DOI: 10.1016/j.ejmech.2017.03.004. View

10.

Ardah M, Ghanem S, Abdulla S, Lv G, Emara M, Paleologou K . Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts. BMC Complement Med Ther. 2020; 20(1):73. PMC: 7076823. DOI: 10.1186/s12906-020-2849-1. View

11.

Razavi S, Seyedebrahimi R, Jahromi M . Biodelivery of nerve growth factor and gold nanoparticles encapsulated in chitosan nanoparticles for schwann-like cells differentiation of human adipose-derived stem cells. Biochem Biophys Res Commun. 2019; 513(3):681-687. DOI: 10.1016/j.bbrc.2019.03.189. View

12.

Athari S, Pourpak Z, Folkerts G, Garssen J, Moin M, Adcock I . Conjugated Alpha-Alumina nanoparticle with vasoactive intestinal peptide as a Nano-drug in treatment of allergic asthma in mice. Eur J Pharmacol. 2016; 791:811-820. DOI: 10.1016/j.ejphar.2016.10.014. View